Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. Bastard P, Michailidis E, Hoffmann HH, Chbihi M, et al. J Exp Med 2021;218.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bastard P, Michailidis E, Hoffmann HH, Chbihi M, et al. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine. J Exp Med 2021;218.
PMID: 33544838